6505--Supply TheraSphere Y-90 Nuclear Med CLEVELAND Louis Stokes VA Medical Center

Page 1 of 1

36C25023Q1123

SPECIAL NOTICE

NOTICE OF INTENT TO SOLE SOURCE

TheraSphere Y-90 Nuclear Med

The Department of Veterans Affairs, The Louis Stokes Cleveland Department of Veteran Affairs Medical Center, 10701 East Boulevard, Cleveland, Ohio 44106 intends to solicit and negotiate with only one source under the authority of FAR 6.302-1(a)(2), Only one responsible source and no other supplies or services will satisfy agency requirements. The VA intends to solicit and negotiate with Boston Scientific, 500 Commander Shea Blvd., Quincy, MA 02171, for TheraSphere Y-90 Doses.

TheraSphere, Y-90 glass microsphere is a therapeutic agent used to treat unresectable primary Hepatocellular Carcinoma. It consists of microscopic glass spheres that are attached to a radioactive isotope (Y-90) and then injected into the patient. The spheres are trapped in the liver where they can treat liver cancer.

The Government believes that only one business can satisfy the agency requirements and intends to negotiate with only one source under the authority of FAR 6.302-1(a)(2), Only one responsible source and no other supplies or services will satisfy agency requirements. Other persons may identify their interest and capability to respond to this requirement by Wednesday, August 30, 2023 at 5PM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government. A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available at this time.  All inquiries must be submitted by email to Gina P. Crank @ gina.crank@va.gov Enter RFQ 36C25023Q1123 TheraSphere Y-90 Nuclear Med in the email subject line.